... called Global HIV Vaccine Research Cryorepository GHRC -
includes eight distinguished institutions in Europe and the USA: the Fraunhofer IBMT in St. Ingbert, the World Health Organisation (WHO) in Geneva, the National Institute for Biological Standards and Control (NIBSC) in London, the San Raffaele Scientific Institute (DIBIT) in Milano, the University of Lund, the University of Saarland, the University of Washington and the National Institutes of Health (NIH).
>> consortium members
The Global HIV Vaccine Research Cryorepository (GHRC) is an advanced HIV Specimen repository where samples obtained from specific Hiv cohorts like early responders or from tests of vaccine candidates are collected and shared in controlled low-temperature conditions for long-term preservation and for sharing among collaborating HIV research laboratories.
GHRC has been established on behalf of the Bill & Melinda Gates Foundation to support the global HIV vaccine research by collecting and offering cryo-preserved HIV specimens of relevance for vaccine development to researchers from the Collaboration for Aids Vaccine Discovery (CAVD).
GHRC also conducts research to develop novel procedures for optimized sample processing and cryo-preservation.
The reagents generated, key information about these reagents, as well as all new technology developed by the GHRC are made available for HIV / AIDS vaccine development.
This will help to ensure that the vaccine candidates will be genetically, immunologically and biologically relevant.